Blastomyces dermatitidis Gilchrist et Stokes, anamorph
Strain Designations
CDC B-838 [766]
Alternate State
Ajellomyces dermatitidis McDonough et Lewis
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Type Strain
no
Antigenic Properties
serotype 2, serotype 2
RefKaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Preceptrol®
no
Morphology
Colonies at 24°C are restricted, whitish, felty; reverse cream-coloured to brownish. Colonies at 37°C are butyrous.
Medium
ATCC® Medium 336: Potato dextrose agar (PDA)
Growth Conditions
Temperature: 26.0°C
Sequenced Data
No DNA sequencing was performed in house on this product.
Name of Depositor
AA Padhye
Chain of Custody
ATCC <<--AA Padhye<<--Dr. Campos-Magalhaes 766
Isolation
human, Mozambique
References
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760